Baxter and ScinoPharm announce exclusive strategic partnership for generic oncology
Baxter and ScinoPharm announced a strategic partnership to develop, manufacture and commercialize five injectable drugs used in a range of cancer treatments, including lung cancer, multiple myeloma and breast cancer, as well as medication to treat nausea and vomiting, side effects of chemotherapy. February 28, 2017